ID   M2GD_HUMAN              Reviewed;         866 AA.
AC   Q9UI17; B2RBN0; B4E1J9;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   10-MAY-2017, entry version 151.
DE   RecName: Full=Dimethylglycine dehydrogenase, mitochondrial;
DE            EC=1.5.8.4 {ECO:0000269|PubMed:27486859};
DE   AltName: Full=ME2GLYDH;
DE   Flags: Precursor;
GN   Name=DMGDH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT PRO-279.
RX   PubMed=10767172; DOI=10.1006/mgme.2000.2980;
RA   Binzak B.A., Vockley J.G., Jenkins R.B., Vockley J.;
RT   "Structure and analysis of the human dimethylglycine dehydrogenase
RT   gene.";
RL   Mol. Genet. Metab. 69:181-187(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS GLY-530 AND PRO-646,
RP   AND VARIANT DMGDHD ARG-109.
RX   PubMed=11231903; DOI=10.1086/319520;
RA   Binzak B.A., Wevers R.A., Moolenaar S.H., Lee Y.-M., Hwu W.-L.,
RA   Poggi-Bach J., Engelke U.F.H., Hoard H.M., Vockley J.G., Vockley J.;
RT   "Cloning of dimethylglycine dehydrogenase and a new human inborn error
RT   of metabolism, dimethylglycine dehydrogenase deficiency.";
RL   Am. J. Hum. Genet. 68:839-847(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   PRO-279.
RC   TISSUE=Synovial cell, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [5]
RP   DISEASE.
RX   PubMed=10102904;
RA   Moolenaar S.H., Poggi-Bach J., Engelke U.F.H., Corstiaensen J.M.B.,
RA   Heerschap A., de Jong J.G.N., Binzak B.A., Vockley J., Wevers R.A.;
RT   "Defect in dimethylglycine dehydrogenase, a new inborn error of
RT   metabolism: NMR spectroscopy study.";
RL   Clin. Chem. 45:459-464(1999).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (3.09 ANGSTROMS) OF 29-866 IN COMPLEX WITH FAD,
RP   CHARACTERIZATION OF VARIANT DMGDHD ARG-109, FUNCTION, CATALYTIC
RP   ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, AND ENZYME
RP   KINETICS.
RX   PubMed=27486859; DOI=10.1111/febs.13828;
RA   Augustin P., Hromic A., Pavkov-Keller T., Gruber K., Macheroux P.;
RT   "Structure and biochemical properties of recombinant human
RT   dimethylglycine dehydrogenase and comparison to the disease-related
RT   H109R variant.";
RL   FEBS J. 283:3587-3603(2016).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] PRO-646, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Catalyzes the demethylation of N,N-dimethylglycine to
CC       sarcosine. Also has activity with sarcosine in vitro.
CC       {ECO:0000269|PubMed:27486859}.
CC   -!- CATALYTIC ACTIVITY: N,N-dimethylglycine + electron-transfer
CC       flavoprotein + H(2)O = sarcosine + formaldehyde + reduced
CC       electron-transfer flavoprotein. {ECO:0000269|PubMed:27486859}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:27486859};
CC       Note=Binds 1 FAD covalently per monomer.
CC       {ECO:0000269|PubMed:27486859};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.4 mM for N,N-dimethylglycine {ECO:0000269|PubMed:27486859};
CC         Vmax=22.1 umol/min/mg enzyme;
CC         Note=kcat is 213 min(-1) for N,N-dimethylglycine.
CC         {ECO:0000269|PubMed:27486859};
CC   -!- PATHWAY: Amine and polyamine degradation; betaine degradation;
CC       sarcosine from betaine: step 2/2.
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UI17-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UI17-2; Sequence=VSP_056959, VSP_056960, VSP_056961,
CC                                  VSP_056962;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: DMGDH deficiency (DMGDHD) [MIM:605850]: Disorder
CC       characterized by fish odor, muscle fatigue with increased serum
CC       creatine kinase. Biochemically it is characterized by an increase
CC       of N,N-dimethylglycine (DMG) in serum and urine.
CC       {ECO:0000269|PubMed:11231903, ECO:0000269|PubMed:27486859}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the GcvT family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF111858; AAF21941.1; -; mRNA.
DR   EMBL; AK303873; BAG64811.1; -; mRNA.
DR   EMBL; AK314736; BAG37277.1; -; mRNA.
DR   EMBL; AC008502; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC016559; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020937; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS4044.1; -. [Q9UI17-1]
DR   RefSeq; NP_037523.2; NM_013391.3. [Q9UI17-1]
DR   UniGene; Hs.655653; -.
DR   PDB; 5L46; X-ray; 3.09 A; A/B=29-866.
DR   PDBsum; 5L46; -.
DR   ProteinModelPortal; Q9UI17; -.
DR   SMR; Q9UI17; -.
DR   BioGrid; 118994; 1.
DR   STRING; 9606.ENSP00000255189; -.
DR   iPTMnet; Q9UI17; -.
DR   PhosphoSitePlus; Q9UI17; -.
DR   BioMuta; DMGDH; -.
DR   DMDM; 296434575; -.
DR   EPD; Q9UI17; -.
DR   PaxDb; Q9UI17; -.
DR   PeptideAtlas; Q9UI17; -.
DR   PRIDE; Q9UI17; -.
DR   DNASU; 29958; -.
DR   Ensembl; ENST00000255189; ENSP00000255189; ENSG00000132837. [Q9UI17-1]
DR   GeneID; 29958; -.
DR   KEGG; hsa:29958; -.
DR   UCSC; uc003kfs.5; human. [Q9UI17-1]
DR   CTD; 29958; -.
DR   DisGeNET; 29958; -.
DR   GeneCards; DMGDH; -.
DR   H-InvDB; HIX0200737; -.
DR   HGNC; HGNC:24475; DMGDH.
DR   HPA; HPA036441; -.
DR   HPA; HPA036442; -.
DR   HPA; HPA077849; -.
DR   MalaCards; DMGDH; -.
DR   MIM; 605849; gene.
DR   MIM; 605850; phenotype.
DR   neXtProt; NX_Q9UI17; -.
DR   OpenTargets; ENSG00000132837; -.
DR   Orphanet; 243343; Dimethylglycine dehydrogenase deficiency.
DR   PharmGKB; PA134947212; -.
DR   eggNOG; KOG2844; Eukaryota.
DR   eggNOG; COG0404; LUCA.
DR   eggNOG; COG0665; LUCA.
DR   GeneTree; ENSGT00530000063120; -.
DR   HOGENOM; HOG000251716; -.
DR   HOVERGEN; HBG081945; -.
DR   InParanoid; Q9UI17; -.
DR   KO; K00315; -.
DR   OMA; YESQEKM; -.
DR   OrthoDB; EOG091G01OO; -.
DR   PhylomeDB; Q9UI17; -.
DR   TreeFam; TF314735; -.
DR   BioCyc; MetaCyc:HS05695-MONOMER; -.
DR   Reactome; R-HSA-6798163; Choline catabolism.
DR   UniPathway; UPA00291; UER00433.
DR   GenomeRNAi; 29958; -.
DR   PRO; PR:Q9UI17; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000132837; -.
DR   CleanEx; HS_DMGDH; -.
DR   ExpressionAtlas; Q9UI17; baseline and differential.
DR   Genevisible; Q9UI17; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0047865; F:dimethylglycine dehydrogenase activity; IMP:UniProtKB.
DR   GO; GO:0009055; F:electron carrier activity; NAS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0006579; P:amino-acid betaine catabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0042426; P:choline catabolic process; TAS:Reactome.
DR   GO; GO:0019695; P:choline metabolic process; NAS:UniProtKB.
DR   GO; GO:0006544; P:glycine metabolic process; IMP:UniProtKB.
DR   Gene3D; 2.40.30.110; -; 1.
DR   InterPro; IPR006076; FAD-dep_OxRdtase.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR032503; FAO_M.
DR   InterPro; IPR013977; GCV_T_C.
DR   InterPro; IPR006222; GCV_T_N.
DR   InterPro; IPR029043; GcvT/YgfZ_C.
DR   Pfam; PF01266; DAO; 1.
DR   Pfam; PF16350; FAO_M; 1.
DR   Pfam; PF01571; GCV_T; 1.
DR   Pfam; PF08669; GCV_T_C; 1.
DR   SUPFAM; SSF101790; SSF101790; 1.
DR   SUPFAM; SSF51905; SSF51905; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; FAD; Flavoprotein; Mitochondrion; Oxidoreductase;
KW   Polymorphism; Reference proteome; Transit peptide.
FT   TRANSIT       1     50       Mitochondrion. {ECO:0000255}.
FT   CHAIN        51    866       Dimethylglycine dehydrogenase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000010767.
FT   NP_BIND      59     60       FAD. {ECO:0000244|PDB:5L46,
FT                                ECO:0000269|PubMed:27486859}.
FT   NP_BIND      80     81       FAD. {ECO:0000244|PDB:5L46,
FT                                ECO:0000269|PubMed:27486859}.
FT   NP_BIND      87     95       FAD. {ECO:0000244|PDB:5L46,
FT                                ECO:0000269|PubMed:27486859}.
FT   NP_BIND     397    402       FAD. {ECO:0000244|PDB:5L46,
FT                                ECO:0000269|PubMed:27486859}.
FT   REGION      580    582       Tetrahydrofolate binding.
FT                                {ECO:0000250|UniProtKB:Q63342}.
FT   REGION      683    685       Tetrahydrofolate binding.
FT                                {ECO:0000250|UniProtKB:Q63342}.
FT   BINDING     219    219       FAD; via amide nitrogen and carbonyl
FT                                oxygen. {ECO:0000244|PDB:5L46,
FT                                ECO:0000269|PubMed:27486859}.
FT   BINDING     251    251       FAD. {ECO:0000250|UniProtKB:Q63342}.
FT   BINDING     676    676       Tetrahydrofolate.
FT                                {ECO:0000250|UniProtKB:Q63342}.
FT   BINDING     744    744       Tetrahydrofolate.
FT                                {ECO:0000250|UniProtKB:Q63342}.
FT   MOD_RES      91     91       Tele-8alpha-FAD histidine.
FT                                {ECO:0000244|PDB:5L46,
FT                                ECO:0000269|PubMed:27486859}.
FT   MOD_RES     114    114       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9DBT9}.
FT   MOD_RES     148    148       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9DBT9}.
FT   MOD_RES     148    148       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9DBT9}.
FT   MOD_RES     168    168       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9DBT9}.
FT   MOD_RES     223    223       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9DBT9}.
FT   MOD_RES     317    317       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9DBT9}.
FT   MOD_RES     319    319       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9DBT9}.
FT   MOD_RES     335    335       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9DBT9}.
FT   MOD_RES     360    360       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9DBT9}.
FT   MOD_RES     434    434       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9DBT9}.
FT   MOD_RES     434    434       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9DBT9}.
FT   MOD_RES     523    523       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9DBT9}.
FT   MOD_RES     523    523       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9DBT9}.
FT   MOD_RES     655    655       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9DBT9}.
FT   MOD_RES     655    655       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9DBT9}.
FT   MOD_RES     764    764       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9DBT9}.
FT   MOD_RES     795    795       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9DBT9}.
FT   VAR_SEQ       1     18       MLRPGAQLLRGLLLRSCP -> MWSCWRNQSSRLDLPGTQ
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056959.
FT   VAR_SEQ      19    398       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056960.
FT   VAR_SEQ     751    774       PADFIGKQALKQIKAKGLKRRLVC -> DQNSCFAHFKEEN
FT                                GWVSRWAIRPY (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056961.
FT   VAR_SEQ     775    866       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056962.
FT   VARIANT     109    109       H -> R (in DMGDHD; shows 10 fold lower
FT                                catalytic efficiency due to lower
FT                                cofactor saturation and reduced thermal
FT                                stability; dbSNP:rs121908331).
FT                                {ECO:0000269|PubMed:11231903,
FT                                ECO:0000269|PubMed:27486859}.
FT                                /FTId=VAR_011505.
FT   VARIANT     279    279       S -> P (in dbSNP:rs532964).
FT                                {ECO:0000269|PubMed:10767172,
FT                                ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_014950.
FT   VARIANT     530    530       A -> G (in dbSNP:rs1805073).
FT                                {ECO:0000269|PubMed:11231903}.
FT                                /FTId=VAR_014951.
FT   VARIANT     646    646       S -> P (in dbSNP:rs1805074).
FT                                {ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:11231903}.
FT                                /FTId=VAR_014952.
FT   CONFLICT    381    381       M -> I (in Ref. 3; BAG37277).
FT                                {ECO:0000305}.
FT   CONFLICT    627    627       L -> F (in Ref. 3; BAG37277).
FT                                {ECO:0000305}.
FT   STRAND       48     55       {ECO:0000244|PDB:5L46}.
FT   HELIX        59     70       {ECO:0000244|PDB:5L46}.
FT   STRAND       74     79       {ECO:0000244|PDB:5L46}.
FT   STRAND       81     83       {ECO:0000244|PDB:5L46}.
FT   TURN         84     88       {ECO:0000244|PDB:5L46}.
FT   HELIX        89     91       {ECO:0000244|PDB:5L46}.
FT   STRAND      101    103       {ECO:0000244|PDB:5L46}.
FT   HELIX       105    123       {ECO:0000244|PDB:5L46}.
FT   STRAND      134    138       {ECO:0000244|PDB:5L46}.
FT   HELIX       141    154       {ECO:0000244|PDB:5L46}.
FT   STRAND      157    159       {ECO:0000244|PDB:5L46}.
FT   STRAND      162    164       {ECO:0000244|PDB:5L46}.
FT   HELIX       166    170       {ECO:0000244|PDB:5L46}.
FT   STRAND      183    187       {ECO:0000244|PDB:5L46}.
FT   HELIX       195    208       {ECO:0000244|PDB:5L46}.
FT   STRAND      212    214       {ECO:0000244|PDB:5L46}.
FT   STRAND      221    224       {ECO:0000244|PDB:5L46}.
FT   STRAND      230    233       {ECO:0000244|PDB:5L46}.
FT   STRAND      238    246       {ECO:0000244|PDB:5L46}.
FT   HELIX       249    251       {ECO:0000244|PDB:5L46}.
FT   HELIX       252    256       {ECO:0000244|PDB:5L46}.
FT   HELIX       257    259       {ECO:0000244|PDB:5L46}.
FT   STRAND      266    275       {ECO:0000244|PDB:5L46}.
FT   HELIX       279    283       {ECO:0000244|PDB:5L46}.
FT   STRAND      290    293       {ECO:0000244|PDB:5L46}.
FT   TURN        294    296       {ECO:0000244|PDB:5L46}.
FT   STRAND      298    303       {ECO:0000244|PDB:5L46}.
FT   STRAND      306    311       {ECO:0000244|PDB:5L46}.
FT   TURN        315    317       {ECO:0000244|PDB:5L46}.
FT   HELIX       323    326       {ECO:0000244|PDB:5L46}.
FT   HELIX       342    344       {ECO:0000244|PDB:5L46}.
FT   HELIX       346    355       {ECO:0000244|PDB:5L46}.
FT   HELIX       357    360       {ECO:0000244|PDB:5L46}.
FT   STRAND      364    374       {ECO:0000244|PDB:5L46}.
FT   STRAND      381    384       {ECO:0000244|PDB:5L46}.
FT   STRAND      391    395       {ECO:0000244|PDB:5L46}.
FT   HELIX       400    415       {ECO:0000244|PDB:5L46}.
FT   TURN        425    427       {ECO:0000244|PDB:5L46}.
FT   HELIX       438    450       {ECO:0000244|PDB:5L46}.
FT   HELIX       451    453       {ECO:0000244|PDB:5L46}.
FT   HELIX       474    478       {ECO:0000244|PDB:5L46}.
FT   HELIX       479    481       {ECO:0000244|PDB:5L46}.
FT   STRAND      482    487       {ECO:0000244|PDB:5L46}.
FT   STRAND      490    496       {ECO:0000244|PDB:5L46}.
FT   HELIX       515    527       {ECO:0000244|PDB:5L46}.
FT   STRAND      530    533       {ECO:0000244|PDB:5L46}.
FT   STRAND      537    544       {ECO:0000244|PDB:5L46}.
FT   HELIX       547    554       {ECO:0000244|PDB:5L46}.
FT   STRAND      564    571       {ECO:0000244|PDB:5L46}.
FT   STRAND      577    585       {ECO:0000244|PDB:5L46}.
FT   STRAND      591    595       {ECO:0000244|PDB:5L46}.
FT   HELIX       597    599       {ECO:0000244|PDB:5L46}.
FT   HELIX       600    613       {ECO:0000244|PDB:5L46}.
FT   STRAND      619    622       {ECO:0000244|PDB:5L46}.
FT   TURN        624    626       {ECO:0000244|PDB:5L46}.
FT   STRAND      630    634       {ECO:0000244|PDB:5L46}.
FT   HELIX       637    642       {ECO:0000244|PDB:5L46}.
FT   TURN        651    653       {ECO:0000244|PDB:5L46}.
FT   STRAND      658    664       {ECO:0000244|PDB:5L46}.
FT   STRAND      667    673       {ECO:0000244|PDB:5L46}.
FT   STRAND      678    687       {ECO:0000244|PDB:5L46}.
FT   HELIX       690    702       {ECO:0000244|PDB:5L46}.
FT   TURN        703    706       {ECO:0000244|PDB:5L46}.
FT   HELIX       712    722       {ECO:0000244|PDB:5L46}.
FT   TURN        727    729       {ECO:0000244|PDB:5L46}.
FT   TURN        737    741       {ECO:0000244|PDB:5L46}.
FT   HELIX       743    745       {ECO:0000244|PDB:5L46}.
FT   STRAND      750    752       {ECO:0000244|PDB:5L46}.
FT   HELIX       757    766       {ECO:0000244|PDB:5L46}.
FT   STRAND      769    777       {ECO:0000244|PDB:5L46}.
FT   STRAND      789    792       {ECO:0000244|PDB:5L46}.
FT   STRAND      795    806       {ECO:0000244|PDB:5L46}.
FT   TURN        807    810       {ECO:0000244|PDB:5L46}.
FT   STRAND      811    819       {ECO:0000244|PDB:5L46}.
FT   HELIX       820    822       {ECO:0000244|PDB:5L46}.
FT   STRAND      828    833       {ECO:0000244|PDB:5L46}.
FT   STRAND      836    842       {ECO:0000244|PDB:5L46}.
FT   TURN        851    853       {ECO:0000244|PDB:5L46}.
SQ   SEQUENCE   866 AA;  96811 MW;  2EC1FA7DCB6C1F8C CRC64;
     MLRPGAQLLR GLLLRSCPLQ GSPGRPRSVC GREGEEKPPL SAETQWKDRA ETVIIGGGCV
     GVSLAYHLAK AGMKDVVLLE KSELTAGSTW HAAGLTTYFH PGINLKKIHY DSIKLYEKLE
     EETGQVVGFH QPGSIRLATT PVRVDEFKYQ MTRTGWHATE QYLIEPEKIQ EMFPLLNMNK
     VLAGLYNPGD GHIDPYSLTM ALAAGARKCG ALLKYPAPVT SLKARSDGTW DVETPQGSMR
     ANRIVNAAGF WAREVGKMIG LEHPLIPVQH QYVVTSTISE VKALKRELPV LRDLEGSYYL
     RQERDGLLFG PYESQEKMKV QDSWVTNGVP PGFGKELFES DLDRIMEHIK AAMEMVPVLK
     KADIINVVNG PITYSPDILP MVGPHQGVRN YWVAIGFGYG IIHAGGVGKY LSDWILHGEP
     PFDLIELDPN RYGKWTTTQY TEAKARESYG FNNIVGYPKE ERFAGRPTQR VSGLYQRLES
     KCSMGFHAGW EQPHWFYKPG QDTQYRPSFR RTNWFEPVGS EYKQVMQRVA VTDLSPFGKF
     NIKGQDSIRL LDHLFANVIP KVGFTNISHM LTPKGRVYAE LTVSHQSPGE FLLITGSGSE
     LHDLRWIEEE AVKGGYDVEI KNITDELGVL GVAGPQARKV LQKLTSEDLS DDVFKFLQTK
     SLKVSNIPVT AIRISYTGEL GWELYHRRED SVALYDAIMN AGQEEGIDNF GTYAMNALRL
     EKAFRAWGLE MNCDTNPLEA GLEYFVKLNK PADFIGKQAL KQIKAKGLKR RLVCLTLATD
     DVDPEGNESI WYNGKVVGNT TSGSYSYSIQ KSLAFAYVPV QLSEVGQQVE VELLGKNYPA
     VIIQEPLVLT EPTRNRLQKK GGKDKT
//
